| Date/Time |
Presentation
theme |
Roles |
Full name |
Affiliation |
| Wednesday,
November 15,2017
（Room A）12:00-13:30 |
FDA/CLIA Requirements for validation of Laboratory Developed Tests in the USA |
Chair |
Tsutomu Nobori,
M.D., Ph.D. |
Professor Emeritus,
Mie University |
| co-Chair |
David S.
Wilkinson,
M.D., Ph.D. |
Professor,Department of
Pathology, Virginia
Commonwealth University |
| Main
Speaker |
Stephen R.
Master, M.D., Ph.D. |
Associate Professor of
Pathology and Laboratory
Medicine, Chief, Clinical
Chemistry Laboratory
Services Director,
Central Lab,
Weill Cornell Medicine,
New York, NY, USA |
| Secindary Speaker |
Sharon Ehrmeyer, Ph.D., MT(ASCP) |
Professor Emeritus,
Pathology and Laboratory
Medicine, University of
Wisconsin-Madison,
Principal, R & S Consultants
Middleton, Wisconsin, USA |
| Discussion
/Q&A |
All members |
| Thursday,
November 16,
2017
（Room 7)
17:30-19:00 |
The Value of
Point-of-Care
Testing in the
Hospital Setting：
Cardiac Example
|
Chair |
Hideo Sakamoto,
Ph.D. |
Department Chair and
Professor Department of
Medical Technology,
Faculty of Health Sciences
Kobe Tokiwa University |
| co-Cha |
to be determined k | |
| Main
Speaker |
Sharon Ehrmeyer,
Ph.D., MT(ASCP) |
Professor Emeritus,
Pathology and Laboratory
Medicine, University of
Wisconsin-Madison,
Principal, R & S
Consultants Middleton,
Wisconsin, USA |
| Secindary Speaker |
Stephen R. Master, MD, PhD |
Associate Professor of
Pathology and Laboratory
Medicine, Chief, Clinical
Chemistry Laboratory
Services Director, Central
Lab, Weill Cornell
Medicine, New York,
NY, USA |
| Japanese
Speaker |
Taiji Furukawa,
M.D.,Ph.D. |
Teikyo University |
| Discussion
/Q&A |
All members |
